C. difficile is a bacterium that causes diarrhea and sometimes can lead to serious intestinal conditions or complications.
VLA84 – Valneva’s Clostridium difficile vaccine candidate that remains on hold
- Valneva has developed VLA84, a vaccine candidate against Clostridium difficile, a leading cause of life threatening, healthcare associated infections worldwide.
- Valneva completed Phase 2 development of VLA84 and could advance into Phase 3 if it chooses to reactivate this program and find a suitable partner.
Additional information about Clostridium difficile: